HealthCare Global Enterprises Limited

NSEI:HCG 株式レポート

時価総額:₹65.6b

HealthCare Global Enterprises 過去の業績

過去 基準チェック /56

HealthCare Global Enterprisesは、平均年間51.3%の収益成長を遂げていますが、 Healthcare業界の収益は、年間 成長しています。収益は、平均年間28.3% 15.5%収益成長率で 成長しています。 HealthCare Global Enterprisesの自己資本利益率は5.9%であり、純利益率は2.7%です。

主要情報

51.3%

収益成長率

53.6%

EPS成長率

Healthcare 業界の成長29.4%
収益成長率15.5%
株主資本利益率5.9%
ネット・マージン2.7%
次回の業績アップデート09 Nov 2024

最近の業績更新

Recent updates

We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned

Sep 19
We Take A Look At Why HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation Is Well Earned

HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

Feb 11
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next

We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation

Sep 14
We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation

A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)

Sep 05
A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)

HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price

May 17
HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price

Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?

Jun 24
Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?

Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings

Jun 03
Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings

Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?

Dec 08
Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?

What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?

Jun 25
What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?

Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares

Mar 14
Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares

The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On

Mar 03
The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On

Here's Why HealthCare Global Enterprises (NSE:HCG) Can Afford Some Debt

Jan 27
Here's Why HealthCare Global Enterprises (NSE:HCG) Can Afford Some Debt

How Many HealthCare Global Enterprises Limited (NSE:HCG) Shares Did Insiders Buy, In The Last Year?

Dec 23
How Many HealthCare Global Enterprises Limited (NSE:HCG) Shares Did Insiders Buy, In The Last Year?

収支内訳

HealthCare Global Enterprises の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NSEI:HCG 収益、費用、利益 ( )INR Millions
日付収益収益G+A経費研究開発費
30 Jun 2419,77052600
31 Mar 2419,1214826240
31 Dec 2318,5923537650
30 Sep 2318,1403717650
30 Jun 2317,47130900
31 Mar 2316,9442937650
31 Dec 2216,1742702740
30 Sep 2215,507-2642740
30 Jun 2214,82769400
31 Mar 2213,9785372740
31 Dec 2113,312-5441900
30 Sep 2112,472-3791900
30 Jun 2111,431-1,63300
31 Mar 2110,134-1,9351900
31 Dec 209,858-1,3492890
30 Sep 209,897-1,2842890
30 Jun 2010,202-1,28400
31 Mar 2010,956-1,0672890
31 Dec 1910,832-7186850
30 Sep 1910,541-5526850
30 Jun 1910,210-39400
31 Mar 199,787-2486850
31 Dec 189,430-1356230
30 Sep 189,004-416230
30 Jun 188,6611246230
31 Mar 188,3072056230
31 Dec 177,9092574400
30 Sep 177,6082784400
30 Jun 177,23721900
31 Mar 177,0012304400
31 Dec 166,7052082980
30 Sep 166,3921332980
30 Jun 166,081672980
31 Mar 165,842-1783200
31 Dec 155,611-33680
30 Sep 155,4949579110
30 Jun 155,32392170
31 Mar 155,19482990
31 Mar 144,513-3562540

質の高い収益: HCGは 高品質の収益 を持っています。

利益率の向上: HCGの現在の純利益率 (2.7%)は、昨年(1.8%)よりも高くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: HCG過去 5 年間で収益を上げており、収益は年間51.3%増加しています。

成長の加速: HCGの過去 1 年間の収益成長率 ( 70.3% ) は、5 年間の平均 ( 年間51.3%を上回っています。

収益対業界: HCGの過去 1 年間の収益成長率 ( 70.3% ) はHealthcare業界30.6%を上回りました。


株主資本利益率

高いROE: HCGの 自己資本利益率 ( 5.9% ) は 低い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘